US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
NYSE
Embotelladora Andina (AKO.A)
Embotelladora Andina (AKO.A) ニュース

Embotelladora Andina (AKO.A)

22.53

-0.02

(-0.09%)

終了 7月9日 5:00AM

22.53

0.00

(0.00%)

取引時間後: 5:00AM

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

NYSE Content Update: HumanX to Ring Remote Bell with 350+ Speakers On Site

NYSE Content Update: HumanX to Ring Remote Bell with 350+ Speakers On Site PR Newswire NEW YORK, April 8...

NYSE Content Update: HumanX to Ring Remote Bell with 350+ Speakers On Site

NYSE Content Update: HumanX to Ring Remote Bell with 350+ Speakers On Site Canada NewsWire NEW YORK, April...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6...

Annual and Transition Report (foreign Private Issuer) (20-f)

126.27155.65122.75138.89171.21135.020000000000NYSE00000000000000925261--12-312022FYfalsefalsefalsefalse000000000...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C...

Schedule 13g
(sc 13g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K ...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K ...

WizardlyRogue35

WizardlyRogue35 11分前

Do I Need SEC Compliance to Build a Crypto Exchange in the US?

Yes, but 2026 is actually the best time to build. SEC's Regulation Crypto introduces a four-year registration exemption for startups, allowing founders to raise up to $75 million without full securities registration. Bitde

bb8675309

bb8675309 24分前

Obama care destroyed our heath care in the United States of America. It was done on purpose. They hate America. Just like they hate Blarcamesine. You cannot take over a world super power externally. You do it internally by keeping the people sick. Imo.

sunspotter

sunspotter 26分前

“ there are only a few employees that receive a small salary. Others are paid in shares”

Please remind me exactly what valuable functions Kevin Bryan Williams - or any other “employee”* - performs for VPLM, a company that has no commercial activities or product of any kind, unless you

nowwhat2

nowwhat2 26分前

https://finance.biggo.com/news/d7d5c43e-0058-426d-8a43-8c936c9bbdbc

Yikes
https://www.google.com/search?q=does+spacex+have+a+larger+market+cap+than+bitcoin+%3F&sca_esv=42eda9f41fdefc69&sxsrf=APpeQnvfky8TDChr-SnuZGdpHdI9-v5wOA%3A1783474289068&source=hp&ei=cahNaorIAZnw0PEP2_OW6

nowwhat2

nowwhat2 32分前

Sound familiar ?
https://finance.biggo.com/podcast/009cfad6d4a6c602

Position, navigation, and timing (PNT) – startups like Mesa Quantum have shrunk the form factor from a coffee mug to a poker chip to a blueberry. These sensors measure local magnetic fields and can provide GPS-

axelvento

axelvento 33分前

Overweight Recommendation Issued On IMRX By Cantor Fitzgerald

https://marketwirenews.com/stock/imrx/news/overweight-recommendation-issued-on-imrx-by-cantor-f-8737586180020191.html?utm_source=rss-twitter

newflow

newflow 39分前

RALTA and LONG-FORM DSSOLUTION, WHAT IS IT ABOUT?.

chereb19

chereb19 46分前

Stop pretending you know every patient's clinical circumstances. "Non-resectable" does not mean "they have nothing to lose." That's your emotional spin, not the FDA's language or the trial protocol.

You're making the same mistake again—taking a medical term and rewriting it to fit you

chereb19

chereb19 49分前

Funny how you've gone from "they'll never get FDA authorization" to "it was only an EFS." The company has described the Early Feasibility pathway in its public filings for years. Pretending this was some last-minute downgrade is just rewriting history.

"Nothing to lose" isn't an FDA s

trender18

trender18 49分前

FITY looks like it's ready to breakout of this sideways trend very soon. https://www.barchart.com/stocks/quotes/FITY/technical-chart?plot=CANDLE&volume=total&data=DO&density=X&pricesOn=1&asPctChange=0&logscale=0&indicators=BBANDS(20,2);RSI(14,100);EXPMA(21);ACCUM;CHKMF(20);EXPMA(34);EXPMA(144)&sym=F

SC8

Stop posting nonsense. A person can live without a thyroid gland. Yes, at a minumum they'd be taking T4 daily for the remainer of their lives, but they can live and live well. The fact these thyroid cancers are non-resectable means they've spread beyond thyroid gland and are inoperable. They hav

William777

William777 53分前

Your words speak loudly. IMO what is coming will set records and reveal the truth about what can happen when greed by a few affect so many.

PickStocks

PickStocks 55分前

18 years and counting.. however RKt will be just fine

johnydollar

johnydollar 56分前

If we take responsibility of our lives we cut down the negative emotions..........

Say i am responsible......

And your anger will melt away like butter.......

https://youtube.com/shorts/TO1wEiA5IVk?is=LWZyrJQWyUPlAGbe

Slaytanic420

Slaytanic420 58分前

Brian and Alfonso are back at it

SC8

It wasn't an IDE application, but you already knew that. They were smart enough to summit an early feasibility application to treat a limited number of patients with nothing to lose, something they could have done decades ago.

Permapumpers morphing this approval into something it isn

lambchops

lambchops 59分前

hope the chart proves it so!
Thanks for the reply CM!

LC

edgm

Truenorth2016

Truenorth2016 1時間前

BIEI Currently Under NDA Discussions For Aerospace Defense Coating Contracts Straight From PR!

"Premier is actively pursuing opportunities across graphene-enhanced defense composites, aerospace coatings, quantum-related materials research, and critical mineral resource in South Americ

Dr_Vonschellan

Dr_Vonschellan 1時間前

Deep Fission Prototype Reactor Canister Arrives at Kansas Site,
Advancing Reactor Proof-of-Concept Program
https://www.businesswire.com/news/home/20260707721954/en/Deep-Fission-Prototype-Reactor-Canister-Arrives-at-Kansas-Site-Advancing-Reactor-Proof-of-Concept-Program

W

chuck1418

chuck1418 1時間前

you got it Aqua. this is a good and informative post. very hard to find this in the subs.

Dr_Vonschellan

Dr_Vonschellan 1時間前

Deep Fission rings July 7 NASDAQ closing Bell
https://www.nasdaq.com/videos/deep-fission-rings-nasdaq-stock-market-closing-bell
skip to 8:57 minutes

The Doctor

4u2nv2

4u2nv2 1時間前

Who is J Coleman 1512 that is the media contact behind the most fabulous MCIC news? Who is this guy?https://investorshub.advfn.com/uimage/uploads/2026/4/5/[mzgoScreen_Shot_2026-04-05_at_1.50.39_AM.png

4u2nv2

4u2nv2 1時間前

I found the media contact if you have any more questions.https://investorshub.advfn.com/uimage/uploads/2026/4/5/[mzgoScreen_Shot_2026-04-05_at_1.50.39_AM.png

Waynewayne

Waynewayne 1時間前

Money making machine!

4u2nv2

4u2nv2 1時間前

https://investorshub.advfn.com/uimage/uploads/2026/4/5/[mzgoScreen_Shot_2026-04-05_at_1.50.39_AM.png

Embotelladora Andina

International bond 1.29%...

Kleangas Energy Technolo... (EM)

Intesa Sanpaolo

European Investment Bank

London Stock Exchange

China Nuclear Energy Tec... (PK)

Xeris Biopharma

Injective Token

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。